ND: |
ME12462851 |
PMID: |
12462851 |
LR: |
20041117 |
CED: |
20021204 |
DCO: |
20030203 |
Titel: |
Is glucosamine worth taking for osteoarthritis? |
Quelle: |
Drug and therapeutics bulletin; VOL: 40 (11); p. 81-3 /200211/ |
PM: |
Print |
SU: |
IM |
Sprache: |
English |
CY: |
England |
JID: |
0112037 |
ISSN: |
0012-6543 |
CO: |
DRTBA |
DT: |
Journal Article |
Schlagwörter |
CT: |
ANTIRHEUMATIC AGENTS/*therapeutic use; GLUCOSAMINE/*therapeutic use; HUMANS; OSTEOARTHRITIS/*drug therapy; RANDOMIZED CONTROLLED TRIALS |
CTG: |
ANTIRHEUMATIKA/*therapeutische Anwendung; GLUCOSAMIN/*therapeutische Anwendung; MENSCH; OSTEOARTHROSE/*Arzneimitteltherapie; RANDOMISIERTE KONTROLLIERTE STUDIEN |
TE: |
Antirheumatic Agents; Glucosamine/3416-24-8 |
CR: |
3416-24-8 |
AB: |
The food supplement glucosamine has been claimed to modify progression of osteoarthritis and is being extensively marketed as a treatment for patients with the condition. In fact, the UK annual market for glucosamine is now estimated to be over 10 million Pounds. Here, we examine whether the supplement has a place in the management of osteoarthritis. |